HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Razelle Kurzrock Selected Research

Ovarian Neoplasms (Ovarian Cancer)

11/2023Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.
2/2023Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy.
1/2021KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.
1/2021Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
1/2019Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
11/2017Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours.
6/2014Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.
5/2014Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway.
2/2014Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors.
1/2014MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Razelle Kurzrock Research Topics

Disease

442Neoplasms (Cancer)
05/2024 - 07/2002
30Neoplasm Metastasis (Metastasis)
03/2021 - 08/2004
28Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 11/2008
23Melanoma (Melanoma, Malignant)
01/2023 - 08/2005
23Fatigue
01/2021 - 02/2004
22Breast Neoplasms (Breast Cancer)
01/2024 - 06/2007
22Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 11/2004
22Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 08/2004
19Thrombocytopenia (Thrombopenia)
01/2020 - 02/2004
17Lung Neoplasms (Lung Cancer)
05/2024 - 12/2007
17Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 03/2011
16Carcinoma (Carcinomatosis)
01/2023 - 03/2008
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2023 - 07/2002
12Castleman Disease (Castleman's Disease)
07/2020 - 09/2007
11Microsatellite Instability
03/2024 - 01/2017
11Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2002
11Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2010
11Hypertension (High Blood Pressure)
03/2020 - 01/2010
10Nausea
03/2020 - 10/2002
9Disease Progression
02/2024 - 07/2008
9Adenocarcinoma
01/2024 - 12/2009
9Hepatocellular Carcinoma (Hepatoma)
09/2022 - 11/2009
9Diarrhea
01/2021 - 01/2008
9Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 02/2002
9Exanthema (Rash)
01/2020 - 04/2004
8Sarcoma (Soft Tissue Sarcoma)
02/2024 - 05/2007
8Fever (Fevers)
07/2020 - 10/2003
8Ewing Sarcoma (Sarcoma, Ewing)
07/2020 - 04/2010
8Infections
07/2020 - 01/2002
8Neutropenia
03/2020 - 11/2010
8Leukemia
01/2008 - 07/2002
7Hodgkin Disease (Hodgkin's Disease)
11/2020 - 02/2004
7Lymphoma (Lymphomas)
11/2018 - 02/2004
7Mucositis
04/2014 - 07/2006
6Circulating Neoplastic Cells
01/2024 - 08/2013
6Erdheim-Chester Disease
01/2023 - 11/2005
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015 - 06/2008
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014 - 10/2002

Drug/Important Bio-Agent (IBA)

68Biomarkers (Surrogate Marker)IBA
05/2024 - 09/2008
33Immune Checkpoint InhibitorsIBA
03/2024 - 01/2017
33DNA (Deoxyribonucleic Acid)IBA
03/2024 - 06/2009
33Bevacizumab (Avastin)FDA Link
01/2020 - 01/2010
31Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 12/2004
30Circulating Tumor DNAIBA
01/2024 - 11/2016
30Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2002
24Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024 - 01/2011
21RNA (Ribonucleic Acid)IBA
04/2024 - 05/2006
19Interleukin-6 (Interleukin 6)IBA
07/2020 - 02/2002
17NivolumabIBA
02/2024 - 01/2016
17Cell-Free Nucleic AcidsIBA
12/2022 - 01/2016
17CytokinesIBA
01/2022 - 08/2002
16Phosphotransferases (Kinase)IBA
03/2023 - 05/2007
16Monoclonal AntibodiesIBA
11/2022 - 08/2004
15ErbB Receptors (EGF Receptor)IBA
10/2023 - 07/2008
15temsirolimusFDA Link
10/2017 - 04/2011
14CurcuminIBA
04/2016 - 11/2004
13AntibodiesIBA
05/2024 - 12/2006
13LigandsIBA
01/2024 - 09/2006
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2011 - 08/2002
11trametinibIBA
03/2024 - 08/2012
11PlatinumIBA
12/2021 - 04/2011
11Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2015 - 04/2007
11tipifarnib (R115777)IBA
04/2011 - 07/2002
10IpilimumabIBA
02/2024 - 01/2020
10Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2005
10Interleukin-8 (Interleukin 8)IBA
08/2013 - 11/2004
10Farnesyltranstransferase (Farnesyltransferase)IBA
04/2011 - 07/2002
9EverolimusFDA Link
03/2024 - 11/2013
9Antineoplastic Agents (Antineoplastics)IBA
03/2021 - 05/2007
9siltuximabIBA
07/2020 - 08/2010
8Messenger RNA (mRNA)IBA
02/2024 - 10/2011
8Trastuzumab (Herceptin)FDA Link
10/2023 - 03/2014
8EnzymesIBA
01/2023 - 11/2004
8Cetuximab (Erbitux)FDA Link
01/2022 - 02/2011
8Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019 - 05/2008
8Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 12/2006
8Sorafenib (BAY 43-9006)FDA Link
02/2015 - 05/2008
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2014 - 02/2002
8NF-kappa B (NF-kB)IBA
12/2009 - 11/2004
7pembrolizumabIBA
03/2024 - 10/2019
7CyclinsIBA
01/2023 - 02/2015
7TOR Serine-Threonine KinasesIBA
10/2022 - 08/2010
7Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 03/2009
7MTOR InhibitorsIBA
11/2020 - 03/2012
7Carboplatin (JM8)FDA LinkGeneric
01/2019 - 04/2011
7Imatinib Mesylate (Gleevec)FDA Link
07/2014 - 08/2006
7Fluorouracil (Carac)FDA LinkGeneric
02/2013 - 08/2004
6dabrafenibIBA
03/2024 - 04/2012
6Sirolimus (Rapamycin)FDA Link
03/2024 - 10/2013
6human ERBB2 proteinIBA
10/2023 - 07/2014
6Lipase (Acid Lipase)FDA Link
01/2020 - 12/2010
6Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 07/2008
6Interferon-alpha (Interferon Alfa)IBA
01/2020 - 01/2002
5pazopanibFDA Link
01/2024 - 06/2015

Therapy/Procedure

243Therapeutics
05/2024 - 01/2002
60Immunotherapy
04/2024 - 04/2015
45Drug Therapy (Chemotherapy)
02/2024 - 01/2002
26Precision Medicine
04/2024 - 09/2011
6Drug Tapering
01/2019 - 04/2004
5Molecular Targeted Therapy
04/2024 - 01/2011